Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednes

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.

Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.

Here are some other stocks moving in today's mid-day session.

Gainers

First Wave BioPharma, Inc. (NASDAQ:FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases.
Cingulate Inc. (NASDAQ:CING) gained 95.2% to $4.08.
RiskOn International, Inc. (NASDAQ:ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024.
Cytokinetics, Incorporated (NASDAQ:CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
AEye, Inc. (NASDAQ:LIDR) rose 61.2% to $3.58.
Vince Holding Corp. (NYSE:VNCE) jumped 42% to $3.2399.
Bit Brother Limited(NASDAQ:BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday.
Nxu, Inc. (NASDAQ:NXU) rose 34% to $4.18.
Virax Biolabs Group Limited (NASDAQ:VRAX) gained 32% to $1.7551.
Jet.AI Inc. (NASDAQ:JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday.
Elicio Therapeutics, Inc. (NASDAQ:ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81.
Matinas BioPharma Holdings, Inc. (NASDAQ:MTNB) gained 24.7% to $0.2518 after the company announced results from a series of in vivo studies demonstrating oral delivery of two LNC-formulated small single-strand oligonucleotides.
Coherus BioSciences, Inc. (NASDAQ:CHRS) shares rose 23.8% to $2.70 after the company reported the FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.
TeraWulf Inc. (NASDAQ:WULF) gained 21.3% to $2.6950 after gaining 3% on Tuesday.
Jiuzi Holdings, Inc. (NASDAQ:JZXN) rose 15.2% to $0.7322.
Burford Capital Limited (NYSE:BUR) gained 14.3% to $15.44.
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) climbed 13.8% to $10.84.
Mobile Global Esports Inc. (NASDAQ:MGAM) shares rose 13.8% to $0.4380 after gaining 33% on Tuesday.
Wheels Up Experience Inc. (NYSE:UP) gained 12.8% to $4.74.
Organogenesis Holdings Inc. (NASDAQ:ORGO) surged 12.2% to $4.4550. BTIG maintained Organogenesis with a Buy and raised the price target from $4 to $6.
Ascent Industries Co. (NASDAQ:ACNT) rose 11.9% to $9.05 as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal.
Mynd.ai, Inc. (NYSE:MYND) gained 10.4% to $5.20.
Coinbase Global, Inc. (NASDAQ:COIN) surged 7.4% to $184.89.
Li Auto Inc. (NASDAQ:LI) gained 5.1% to $36.20.

Losers

Hallmark Financial Services, Inc. (NASDAQ:HALL) shares fell 31.4% to $1.0764. Hallmark Financial Services gave notice to Nasdaq of intention to voluntarily delist its shares of common stock from Nasdaq Global Market.
Baosheng Media Group Holdings Limited (NASDAQ:BAOS) fell 29.5% to $4.1050.
Nukkleus Inc. (NASDAQ:NUKK) shares fell 28.8% to $2.60 after jumping around 11% on Tuesday.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) fell 20.4% to $7.07 after the FDA placed a clinical hold on the IOV-LUN-202 trial in response to a recently reported Grade 5 adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.
Mobix Labs, Inc. (NASDAQ:MOBX) shares fell 17.1% to $5.80 after surging over 34% on Tuesday.
Color Star Technology Co., Ltd. (NASDAQ:ADD) dipped 15.4% to $0.33.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 15.4% to $2.20. Bluejay Diagnostics announced initiation of multicenter clinical study evaluating symphony IL-6 in sepsis patients.
Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) declined 15% to $0.7880.
ARB IOT Group Limited (NASDAQ:ARBB) fell 14.4% to $2.2155 after surging 175% on Tuesday.
Asset Entities Inc. (NASDAQ:ASST) declined 13.7% to $0.6120.
Volcon, Inc. (NASDAQ:VLCN) fell 12.7% to $0.1224. On Dec 19, Volcon got deficiency letter from Nasdaq that the company did not meet minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
Smart for Life, Inc. (NASDAQ:SMFL) shares fell 10.8% to $1.63 after declining 7% on Tuesday.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares fell 9.1% to $0.2090. Brainstorm Cell Therapeutics shares gained 16% on Tuesday after the company announced that it was granted patents for Allogeneic Exosome Platform-Product in neurological disorder treatments.
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) shares fell 8.7% to $1.16. Inspira Technologies shares gained 5% on Tuesday after the company announced 95% accuracy results for HYLA Blood Sensor. Additionally, the company plans FDA submission for clearance in 2024.
InnSuites Hospitality Trust (NYSE:IHT) fell 8.6% to $1.4250.
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) shares fell 6.8% to $0.5510. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.
Canopy Growth Corporation (NASDAQ:CGC) fell 6.2% to $5.31.